Serum Autoantibodies in Predicting the Efficacy of Anti-PD-1 Treatment in Patients With Advanced NSCLC
Clinical trial NCT04372732 · UNKNOWN
Trial details
- NCT number
- NCT04372732
- Sponsor
- Shanghai Pulmonary Hospital, Shanghai, China
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2020-09-01
- Primary completion
- 2022-06-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.